New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
January 3, 2013
10:00 EDTFDO, CCO, WLP, SBAC, LSI, BIIB, STI, UNH, MS, ALTR, AMD, WAT, AFL, GEVA, LYB, CY, AOSOn The Fly: Analyst Downgrade Summary
Today's noteworthy downgrades include: A.O. Smith (AOS) downgraded to Neutral from Buy at Janney Capital... AMD (AMD) downgraded to Underweight from Equal Weight at Barclays... Altera (ALTR) downgraded to Equal Weight from Overweight at Barclays... Biogen (BIIB) downgraded to Neutral from Overweight at Piper Jaffray... Cypress Semiconductor (CY) downgraded to Equal Weight from Overweight at Barclays... LSI Corp. (LSI) downgraded to Equal Weight from Overweight at Barclays... LyondellBasell (LYB) downgraded to Neutral from Buy at Citigroup... Morgan Stanley (MS) downgraded to Reduce from Neutral at SunTrust... SBA Communications (SBAC) downgraded to Neutral from Outperform at Macquarie... Synageva (GEVA) downgraded to Neutral from Overweight at Piper Jaffray... UnitedHealth (UNH) downgraded to Hold from Buy at Deutsche Bank... Wellpoint (WLP) downgraded to Hold from Buy at Deutsche Bank... Aflac (AFL) downgraded to Neutral from Overweight at JPMorgan... SunTrust (STI) downgraded to Market Perform from Outperform at Raymond James... Clear Channel Outdoor (CCO) downgraded to Underperform from Neutral at Wedbush... Waters (WAT) downgraded to Market Perform from Outperform at Leerink... Family Dollar (FDO) downgraded to Market Perform from Outperform at Raymond James.
News For AOS;AMD;BIIB;CY;ALTR;LSI;LYB;MS;SBAC;GEVA;UNH;WLP;AFL;STI;CCO;WAT;FDO From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 >>
August 19, 2015
17:46 EDTBIIBApplied Genetic says Biogen collaboration effective, equity investment closed
Subscribe for More Information
17:11 EDTSTISunTrust initiated with a Neutral at Sterne Agee CRT
Subscribe for More Information
14:42 EDTMSBanks cooperate on data company to lower costs, WSJ says
Subscribe for More Information
10:00 EDTAFLOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
06:16 EDTAFLAflac downgraded to Underperform from Neutral at BofA/Merrill
August 18, 2015
10:00 EDTCCOOn The Fly: Analyst Downgrade Summary
Subscribe for More Information
09:02 EDTLYBLyondellBasell announces sale of Argentina-based Petroken
LyondellBasell announced that YPF S.A. and Grupo Inversor Petroquimica S.L. have accepted an offer to purchase LyondellBasell's Argentina-based, wholly-owned subsidiary Petroken Petroquimica Ensenada S.A. The sale is expected to close in late 2015 following Brazilian antitrust authority approval. The transaction is valued at $145M on a debt and cash free basis. Based on working capital estimates as of June 30, 2015, expected cash proceeds are $162M. Petroken operates a 180 kiloton polypropylene plant in Ensenada and is a leading polypropylene producer in Argentina.
08:21 EDTBIIBBiogen long-term outlook still positive, says RBC Capital
Subscribe for More Information
07:57 EDTUNHMagellan Iowa loss largely priced into shares, says Jefferies
Subscribe for More Information
07:57 EDTCYCypress Semiconductor volatility elevated
Subscribe for More Information
07:05 EDTCCOOUTFRONT Media downgraded to Market Perform from Outperform at Wells Fargo
Subscribe for More Information
07:05 EDTBIIBBiogen, ALS Association, Columbia collaborate to drive understanding of ALS
Biogen, the ALS Association and Columbia University Medical Center announced a new collaboration to better understand the differences and commonalities in the ALS disease process and how genes influence the clinical features of the disease. The project, "Genomic Translation for ALS Clinical care", will involve a combination of next generation genetic sequencing and detailed clinical phenotyping in 1500 people with ALS. The goal of the project is to provide a basis for the development of precision medicine, or more individually tailored therapies for ALS. "We want to bring genomics right to the point of care in ALS where instead of focusing on retrospective DNA samples with limited clinical information, we focus on patients who are under active clinical management," said ALS Association Chief Scientist Lucie Bruijn, Ph.D., M.B.A. "By focusing on patients seen by participating ALS clinics, this project will allow investigators to ask how different genetic causes of ALS translate into different clinical consequences."
07:04 EDTCCOClear Channel Outdoor downgraded to Market Perform at Wells Fargo
Subscribe for More Information
August 17, 2015
16:12 EDTUNHMagellan drops after Iowa picks four others for Medicaid
Subscribe for More Information
15:57 EDTUNHUnitedHealth up 2.4% after being awarded Iowa healthcare contract
15:55 EDTUNHWellCare, Amerigroup, UnitedHealth, AmeriHealth awarded Iowa healthcare contract
Reference Link
07:03 EDTBIIBBiogen: Clinical data supports long-term safety, efficacy of Alprolix
New clinical data support the long-term safety and efficacy of ALPROLIX in people with severe hemophilia B treated for up to two years, Biogen announced. Participants in the Phase 3, open-label extension study, B-YOND, maintained low bleeding rates with one to two week prophylaxis regimens, according to data from an interim analysis. Investigators presented these interim results for the first time at the 67th Annual Meeting for the National Hemophilia Foundation in Dallas. B-YOND is a multi-year study for people with severe hemophilia B who completed the Phase 3 pivotal B-LONG or Kids B-LONG studies. In this interim analysis, the median time on ALPROLIX during B-YOND was 27.6 months for adults and adolescents, and 47.7 weeks for children under age 12. The study's primary endpoint is inhibitor development, and no inhibitors have been reported to-date. There were three prophylactic dosing options for adult, adolescent, and pediatric participants in the B-YOND trial - weekly, individualized, and modified prophylaxis. An episodic treatment arm was also available for adult and adolescent patients.
August 14, 2015
17:24 EDTUNHUnitedHealth names Tom Roos as Chief Accounting Officer
Subscribe for More Information
06:00 EDTCYCypress Semiconductor implied volatility of 51 at upper end of index
Subscribe for More Information
06:00 EDTBIIBStocks with implied volatility below IV index mean; BIIB GOOG
Subscribe for More Information
1 | 2 | 3 >>

Sign up for a free trial to see the rest of the stories you've been missing.
I agree to the theflyonthewall.com disclaimer & terms of use